COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study - Top-Institutions - MDSpire

COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

  • By

  • Quincy Hofsink

  • Birgit I Lissenberg-Witte

  • Sabine Haggenburg

  • Abraham Goorhuis

  • Mette D Hazenberg

  • Caroline E Rutten

  • Paul den Tex

  • Elisabeth G E de Vries

  • Astrid A M van der Veldt

  • Jeanet M Kemmeren

  • Nicolette F de Keizer

  • Peter C Huijgens

  • Avinash G Dinmohamed

  • Annika van Roon

  • Joyce Pijpers

  • Caren van Roekel

  • Susan van den Hof

  • Susan J M Hahné

  • Brechje de Gier

  • Jarom Heijmans

  • Inger S Nijhof

  • October 14, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Immunology

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Transplantation
    • Infectious Diseases

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #5

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Immunology
    • Epidemiology

Original Source(s)

COVID-19 Vaccine Effectiveness in Patients With Hematologic Malignancies: A Nationwide Cohort Study

  • by Quincy Hofsink, Birgit I Lissenberg-Witte, Sabine Haggenburg, Abraham Goorhuis, Mette D Hazenberg, Caroline E Rutten, Paul den Tex, Elisabeth G E de Vries, Astrid A M van der Veldt, Jeanet M Kemmeren, Nicolette F de Keizer, Peter C Huijgens, Avinash G Dinmohamed, Annika van Roon, Joyce Pijpers, Caren van Roekel, Susan van den Hof, Susan J M Hahné, Brechje de Gier, Jarom Heijmans, Inger S Nijhof

  • October 14, 2025

Related Content

The CRISPR-powered Diagnostic SLEUTH

Novel DNA-guided system may support future RNA diagnostics and mutation detection

  • May 22, 2026

  • 2 min
Analysis of the epidemic situation of respiratory pathogens in central and southern China before and after the COVID-19 pandemic

Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination

Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.